CYBB and prostate carcinoma: Endosomal NOX2 activity was recently shown to play an important role in progression of prostate cancer [132], which could be targeted (for instance with antibodies) with antioxidant-carrying small particles for exclusive uptake via endocytosis by tumor cells [133].